Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

This early-stage study tests a new drug called TQB2922, given as a shot under the skin, in about 42 people with advanced cancers that have not responded to standard treatments. The main goal is to check the drug's safety and how the body processes it. This is a Phase 1 trial, so …

This study tests an experimental drug called TQC2731 for people with chronic sinusitis and nasal polyps (growths in the nose). The drug is given as an injection and aims to reduce inflammation, shrink polyps, and improve nasal congestion. About 246 adults aged 18 to 75 will parti…

This study tests an experimental drug called TQB2934 in 70 adults with systemic light chain amyloidosis, a rare disease where abnormal proteins build up in organs. The goal is to see if the drug can improve blood markers and is safe for people who have already tried other treatme…

This study tests whether a new drug combination (TQB2868 injection plus anlotinib capsules) with chemotherapy can help people with metastatic pancreatic cancer live longer compared to standard chemotherapy alone. About 566 adults aged 18-75 with stage IV pancreatic cancer will ta…

This study tests a new injection called TQH2722 for people with seasonal allergic rhinitis (hay fever). About 300 adults aged 18-75 who had poor symptom control in past pollen seasons will receive the injection plus their usual allergy treatments. The goal is to see if the inject…